Apolipoprotein C-III: Risk-factor, Regulator of Triglyceride-rich Lipoprotein Metabolism and Therapeutic Target.
Saved in:
| Title: | Apolipoprotein C-III: Risk-factor, Regulator of Triglyceride-rich Lipoprotein Metabolism and Therapeutic Target. |
|---|---|
| Authors: | Björnson E; Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden., Adiels M; Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden., Taskinen MR; Research Program for Clinical and Molecular Metabolism, University of Helsinki, Helsinki, Finland., Packard CJ; Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK., Borén J; Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden. jan.boren@wlab.gu.se.; Wallenberg Laboratory, Sahlgrenska University Hospital, Gothenburg, Sweden. jan.boren@wlab.gu.se. |
| Source: | Current atherosclerosis reports [Curr Atheroscler Rep] 2026 Feb 16; Vol. 28 (1), pp. 22. Date of Electronic Publication: 2026 Feb 16. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 100897685 Publication Model: Electronic Cited Medium: Internet ISSN: 1534-6242 (Electronic) Linking ISSN: 15233804 NLM ISO Abbreviation: Curr Atheroscler Rep Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
